bm‑t is pleased to announce that seven of its investee partners have already closed financing rounds in 2018. Over 10M EUR was raised by Biano GMP, ifesca, JenID, MasterPIM, OnCGnostics, Preventicus, and SiOptica, securing the necessary financing for important, value-driving advancements.
These investment rounds continued the strong momentum from 2017, in which over 150M EUR was raised by 21 of bm‑t´s investee partners. Kevin Reeder, CEO of bm‑t sees the continuation of the fund raising momentum as a great sign for Thüringen and a strong signal to the investment community of the attractiveness of investing in the region. “With two very successful and highly-publicized exits last year – a sale to Facebook and a Nasdaq IPO – bm‑t has appeared on many investor´s radar screens. We are witnessing ever greater interest in co-investments with bm‑t here in Thüringen, which will serve us well as we strive to catalyze the next Thüringen Champions.”
Of particular note was that two of the 2018 financings attracted multiple million Euros from outside of Germany, with one investment coming from Switzerland and another from Belgium. “We know that our companies have impactful innovations and great substance, and we are delighted to see that other investors outside of Germany have recognized this and will now work with us as co-investors to help drive these companies forward,” said Reeder.
About Biano GMP
BianoGMP was founded in August 2017 with the aim of being a GMP service provider for small to medium batch sizes in the field of oligonucleotides. By offering outsourced small and medium sized batch production, BianoGMP will allow early-stage biotech companies to reduce costs and shorten their development timelines. The company is also developing methods to offer a wide-range of oligo development and production capabilities.
More information about BianoGMP can be found under: http://bianoscience.com/GMP_Oligonucleotides
Founded 2016 in Ilmenau, ifesca offers AI-based decision support solutions and services for the energy market. High-quality forecasts for energy-related time-series and optimized operation schedules for energy production are provided through a specialized IoT-platform ifesca.AIVA. The “as a Service”-solutions of ifesca massively help to automate decision processes, thus increasing the quality of forecast and reducing manual efforts and process complexity. The services are provided for any participant of the global energy markets. Working in these markets for over 15 years and its scientific background enable the ifesca-team to create its unprecedented AI-solutions.
jenID Solutions offers flexible software solutions to customers in financial services, insurance, car rental, telecommunication and more industries that are tailored to their needs and that allow them to perform secure identity checks anywhere in the world in real-time. As such, the company knows who is accessing, using or borrowing its products. jenID thus contributes to the protection of end users› identities and prevents fraud.
More information about jenID Solutions can be found under: www.jenidsolutions.com
MasterPIM developes browser-based tools for efficient product-information-management (PIM) systems. The modular design allows for easy data conversion without project management and laborious integration. Thus, permitting a fully-scalable solution for large marketplaces and manufacturers alike. MasterPIM works with standardized products in order to create a seamless onboarding process.
More information about MasterPIM can be found under: http://www.masterpim.de/
oncgnostics GmbH is a spin-off from the university women’s hospital Jena and was founded early in 2012. As a molecular diagnostic company oncgnostics is specialized on cancer diagnostics. Oncgnostics tests target epigenetic changes, so-called DNA methylations, that typically occur in cancer cells. The patented biomarkers which are evaluated using a specific algorithm are the core of the products and provide thus the basis for the company’s activities.
More information about oncgnostics can be found under http://www.oncgnostics.com/
Preventicus turns your smart phone into a medical measuring instrument, enabling users to perform medical checkups at home and receive tailor-made prevention measures for maintaining one’s own health. Unique selling points of Preventicus include superior bio-analytical algorithms backed by clinical evidence that make risk screening possible via smartphone. Health partners can be networked with users and can monitor the app-generated health profile and impact of the individualized prevention measures.
More information about Preventicus can be found under http://www.preventicus.com/
SiOptica GmbH was founded in 2013 in Jena, Germany with the goal to establish innovative and special solutions in the market, primarily in the field of optics. The company offers technologies in the field of privacy filters that can protect screen data from unauthorized views without suffering from associated brightness loss and can operate in public or private modes. SiOptica´s solutions offer great advantages in the areas of ATM/Banking/Retail/Payment Terminals, logistics/secure access, data security, as well as consumer electronics.
More information about SiOptica can be found under www.sioptica.com
Erfurt-based, bm‑t beteiligungsmanagement Thüringen (bm|t) – a subsidiary of the Thuringia Development Bank, is the first address for investments in Thuringia, Germany. bm‑t currently manages eight investment funds with a total volume of 320M EUR. bm‑t invests in innovative companies with strong growth potential across all sectors and all phases of the corporate lifecycle.
More information about bm‑t can be found under www.bm‑t.com